John Jiang
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Cells and Metastasis
Papers in
-
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 4
-
- Ovarian cancer diagnosis and treatment 1
- Co-authors
- Yixin Wang (4 shared papers)Yi Zhang (1 shared paper)Howard L. McLeod (1 shared paper)Tim Jatkoe (1 shared paper)Matthew G. Mutch (1 shared paper)Dmitri Talantov (1 shared paper)Ben O’Leary (2 shared papers)Sherene Loi (2 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Journal of Molecular Diagnostics (2 papers)Cancer (2 papers)Clinical Cancer Research (1 paper)Science Translational Medicine (1 paper)
- Partner nations
- United StatesNetherlandsGermany
In The Last Decade
John Jiang
16 papers receiving 1.6k citations
John Jiang's Hit Papers
Peers
Comparison fields: 5 of 58
- Cancer Research 715
- Oncology 403
- Pulmonary and Respiratory Medicine 379
- Pathology and Forensic Medicine 146
- Genetics 181
Countries citing papers authored by John Jiang
This map shows the geographic impact of John Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Jiang more than expected).
Fields of papers citing papers by John Jiang
This network shows the impact of papers produced by John Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Jiang. The network helps show where John Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside John Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Plasma ESR1 Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer Hit paper breakdown → | 2016 | 605 |
| 2 | 2004 | 376 | |
| 3 | 2011 | 186 | |
| 4 | 2012 | 80 | |
| 5 | 2019 | 80 | |
| 6 | 2009 | 74 | |
| 7 | 2001 | 46 | |
| 8 | 2011 | 43 | |
| 9 | 2019 | 42 | |
| 10 | 2012 | 32 | |
| 11 | 2012 | 30 | |
| 12 | 2011 | 22 | |
| 13 | 2013 | 12 | |
| 14 | 2020 | 12 | |
| 15 | 2021 | 11 | |
| 16 | 2007 | 6 |
About John Jiang
John Jiang is a scholar working on Cancer Research, Reproductive Medicine, Oncology, Pulmonary and Respiratory Medicine and Pharmacology, having authored 16 papers that have together received 1.7k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (6 papers), Breast Cancer Treatment Studies (4 papers), Pancreatic and Hepatic Oncology Research (2 papers), Advanced Breast Cancer Therapies (2 papers), Inflammatory mediators and NSAID effects (1 paper), Gene expression and cancer classification (1 paper), Ovarian cancer diagnosis and treatment (1 paper) and Acute Myocardial Infarction Research (1 paper). The work is most often cited by research in Cancer Research (715 citations), Oncology (403 citations), Pulmonary and Respiratory Medicine (379 citations), Pathology and Forensic Medicine (146 citations) and Genetics (181 citations). John Jiang has collaborated with scholars based in United States, Netherlands and Germany. Frequent co-authors include Yixin Wang, Yi Zhang, Howard L. McLeod, Tim Jatkoe, Matthew G. Mutch, Dmitri Talantov, Ben O’Leary, Sherene Loi, Fabrice André and Massimo Cristofanilli. Their work appears in journals such as Journal of Clinical Oncology, Journal of Molecular Diagnostics, Cancer, Clinical Cancer Research and Science Translational Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.